Beth C. Seidenberg - Insider Trading & Ownership
-
Entity
-
Individual
-
Summary
-
The estimated net worth of Beth C. Seidenberg is at least $23.8M dollars as of October 30, 2024. Beth C. Seidenberg is the Director of Progyny, Inc. and owns shares of Progyny, Inc. (PGNY) stock worth about $8.67M. Beth C. Seidenberg is the Director of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $8.33M. Beth C. Seidenberg is the Director of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $6.72M. Beth C. Seidenberg is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $45.1K.